Cite
HARVARD Citation
Higashiyama, T. et al. (2022). Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE). European journal of cancer. pp. 210-218. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Higashiyama, T. et al. (2022). Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE). European journal of cancer. pp. 210-218. [Online].